Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126683131 | 12668313 | 1 | I | 20080617 | 20160819 | 20160819 | EXP | PHHY2008BR40479 | NOVARTIS | 0.00 | F | Y | 90.00000 | KG | 20160819 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126683131 | 12668313 | 1 | PS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF (80 MG VAL/12.5MG HCT), UNK | 20818 | 1 | DF | TABLET | |||||||
| 126683131 | 12668313 | 2 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF (160 MG VAL/25 MG HCT), UNK | 20818 | 1 | DF | TABLET | |||||||
| 126683131 | 12668313 | 3 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF (160/25MG), UNK | 20818 | 1 | DF | TABLET | |||||||
| 126683131 | 12668313 | 4 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 1 DF (320/25 MG), UNK | 20818 | 1 | DF | TABLET | |||||||
| 126683131 | 12668313 | 5 | SS | DIOVAN | VALSARTAN | 1 | Oral | 80 MG, QD | Y | 0 | 80 | MG | TABLET | QD | |||||
| 126683131 | 12668313 | 6 | SS | DIOVAN | VALSARTAN | 1 | Oral | 160 MG, QD | Y | 0 | 160 | MG | TABLET | QD | |||||
| 126683131 | 12668313 | 7 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126683131 | 12668313 | 1 | Hypertension |
| 126683131 | 12668313 | 5 | Hypertension |
| 126683131 | 12668313 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126683131 | 12668313 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126683131 | 12668313 | Blood pressure fluctuation | |
| 126683131 | 12668313 | Blood pressure increased | |
| 126683131 | 12668313 | Diabetes mellitus inadequate control | |
| 126683131 | 12668313 | Drug ineffective | |
| 126683131 | 12668313 | Fatigue | |
| 126683131 | 12668313 | Gait disturbance | |
| 126683131 | 12668313 | Nervousness | |
| 126683131 | 12668313 | Overweight | |
| 126683131 | 12668313 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126683131 | 12668313 | 1 | 2009 | 0 | ||
| 126683131 | 12668313 | 2 | 2002 | 0 | ||
| 126683131 | 12668313 | 6 | 2009 | 0 |